Defense Production and Active Pharmaceutical Ingredients Act

Bill: 118-hr-6895
Sponsor: full_name: Rep. Slotkin, Elissa [D-MI-7]
Introduced: 2023-12-22
Policy area: Health
Latest action: action_date: 2023-12-22
text: Referred to the House Committee on Armed Services.

Summaries:

tv_txt: I 118th CONGRESS 1st Session H. R. 6895 IN THE HOUSE OF REPRESENTATIVES December 22, 2023 Ms. Slotkin introduced the following bill; which was referred to the Committee on Armed Services A BILL To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.

1. Short title This Act may be cited as the Defense Production and Active Pharmaceutical Ingredients Act . 2. Modification of support for research and development of bioindustrial manufacturing processes Section 215(c)(1) of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 ( Public Law 117–263 ; 10 U.S.C. 4841 note) is amended by inserting active pharmaceutical ingredients, key starting materials for such ingredients, after commodity chemicals, .